Guidelines for xenotransplantation [7]

New England Journal of Medicine

Volumn 349, Issue 13, 2003, Pages 1294-1295

  Sykes, Megan ^a   Sandrin, Mauro ^b   D'Apice, Anthony ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b AUSTIN RESEARCH INSTITUTE   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DNA MODIFICATION; GOAT; GOVERNMENT; HUMAN; HUMORAL IMMUNITY; LETTER; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH; SERTOLI CELL; SERTOLI CELL TRANSPLANTATION; SHARK; SWINE; XENOTRANSPLANTATION; ANIMAL; ETHICS; HEALTH CARE AND PUBLIC HEALTH; INTERNATIONAL COOPERATION; LEGAL ASPECT; STANDARD; XENOGRAFT;

HEALTH CARE AND PUBLIC HEALTH;

ANIMALS; HUMANS; INTERNATIONAL COOPERATION; PRACTICE GUIDELINES; TRANSPLANTATION, HETEROLOGOUS;

EID: 85047689291     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200309253491320     Document Type: Letter

References (5)

1. Phelps CJ, Koike C, Vaught TD, et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 2003;299:411-4.
2. Allan JS. Cross-species infection: no news is good news? Nat Med 1998;4:644-5.
3. Paradis K, Langford G, Long Z, et al. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. Science 1999;285:1236-41.
4. Guidance for Industry: source animal, product, preclinical, and clinical issues concerning the use of xenotransplantation products in humans. Rockville, Md.: Food and Drug Administration, 2001.
5. Jayaraman KS. Goats to de-liver cells for transplants in India. Nat Med 2003;9:491.